128 related articles for article (PubMed ID: 38335772)
1. Antiviral treatment significantly reduces the levels of CXCL9, CXCL10 and CXCL11 in chronic hepatitis C.
Radmanić L; Šimičić P; Bodulić K; Vince A; Zidovec-Lepej S
Cytokine; 2024 Apr; 176():156529. PubMed ID: 38335772
[TBL] [Abstract][Full Text] [Related]
2. [THE ROLE OF CYTOKINES AND CHEMOKINES IN LABORATORY DIAGNOSTIC OF CHRONIC VIRAL HEPATITIS C].
Semenov AV; Arsentieva NA; Lubimova NE; Tulienev SV; Basina VV; Esaulenko EV; Totolyan AA
Klin Lab Diagn; 2015 Aug; 60(8):45-51. PubMed ID: 26596048
[TBL] [Abstract][Full Text] [Related]
3. Study of CXCL9-11 gene polymorphisms in liver fibrosis among patients with chronic hepatitis C.
Magri MC; Alvarez MSM; Iogi AA; Alves GM; Manchiero C; Dantas BP; Prata TVG; Nunes AKDS; Tengan FM
Pathog Dis; 2021 Mar; 79(3):. PubMed ID: 33476381
[TBL] [Abstract][Full Text] [Related]
4. Chemokine CXCL10 at week 4 of treatment predicts sustained virological response in patients with chronic hepatitis C.
Kurelac I; Lepej SZ; Grlgic I; Gorenec L; Papic N; Dusek D; Barsic B; Vince A
J Interferon Cytokine Res; 2012 Aug; 32(8):386-91. PubMed ID: 22799464
[TBL] [Abstract][Full Text] [Related]
5. CXCL9, CXCL10 and CXCL11 polymorphisms are associated with sustained virologic response in HIV/HCV-coinfected patients.
Pineda-Tenor D; Berenguer J; Jiménez-Sousa MA; Guzmán-Fulgencio M; Aldámiz-Echevarria T; Carrero A; García-Álvarez M; Diez C; Tejerina F; Briz V; Resino S
J Clin Virol; 2014 Nov; 61(3):423-9. PubMed ID: 25218243
[TBL] [Abstract][Full Text] [Related]
6. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
[TBL] [Abstract][Full Text] [Related]
7. Serum CXCL5 Detects Early Hepatocellular Carcinoma and Indicates Tumor Progression.
Laschtowitz A; Lambrecht J; Puengel T; Tacke F; Mohr R
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982370
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
[TBL] [Abstract][Full Text] [Related]
9. CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features.
Kameda M; Otsuka M; Chiba H; Kuronuma K; Hasegawa T; Takahashi H; Takahashi H
PLoS One; 2020; 15(11):e0241719. PubMed ID: 33137121
[TBL] [Abstract][Full Text] [Related]
10. The combination of CXCL9, CXCL10 and CXCL11 levels during primary HIV infection predicts HIV disease progression.
Yin X; Wang Z; Wu T; Ma M; Zhang Z; Chu Z; Hu Q; Ding H; Han X; Xu J; Shang H; Jiang Y
J Transl Med; 2019 Dec; 17(1):417. PubMed ID: 31836011
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of CXCL11 and CXCL12 are biomarkers of cirrhosis in patients with chronic hepatitis C infection.
Chalin A; Lefevre B; Devisme C; Barget N; Amiot L; Samson M
Cytokine; 2019 May; 117():72-78. PubMed ID: 30826602
[TBL] [Abstract][Full Text] [Related]
12. Single nucleotide polymorphisms of CXCL9-11 chemokines are associated with liver fibrosis in HIV/HCV-coinfected patients.
Pineda-Tenor D; Berenguer J; García-Álvarez M; Guzmán-Fulgencio M; Carrero A; Aldámiz-Echevarria T; Tejerina F; Diez C; Jiménez-Sousa MA; Fernández-Rodríguez A; Munoz-Fernandez MA; Resino S
J Acquir Immune Defic Syndr; 2015 Apr; 68(4):386-95. PubMed ID: 25559603
[TBL] [Abstract][Full Text] [Related]
13. Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C.
Butera D; Marukian S; Iwamaye AE; Hembrador E; Chambers TJ; Di Bisceglie AM; Charles ED; Talal AH; Jacobson IM; Rice CM; Dustin LB
Blood; 2005 Aug; 106(4):1175-82. PubMed ID: 15860662
[TBL] [Abstract][Full Text] [Related]
14. Increased serum levels of CCL3, CXCL8, CXCL9, and CXCL10 in rosacea patients and their correlation with disease severity.
Liu T; Li J; Deng Z; Chen M; Sha K; Xiao W; Xie H; Zhao Z
J Dermatol; 2022 May; 49(5):525-533. PubMed ID: 35233832
[TBL] [Abstract][Full Text] [Related]
15. Proinflammatory Chemokine Levels in Cerebrospinal Fluid of Patients with Neuroinvasive Flavivirus Infections.
Zidovec-Lepej S; Bodulić K; Bogdanic M; Gorenec L; Savic V; Grgic I; Sabadi D; Santini M; Radmanic Matotek L; Kucinar J; Barbic L; Zmak L; Ferenc T; Stevanovic V; Antolasic L; Milasincic L; Hruskar Z; Vujica Ferenc M; Vilibic-Cavlek T
Microorganisms; 2024 Mar; 12(4):. PubMed ID: 38674602
[TBL] [Abstract][Full Text] [Related]
16. CXCL8, CXCL9, CXCL10, and CXCL11 as biomarkers of liver injury caused by chronic hepatitis B.
Yu X; Chen Y; Cui L; Yang K; Wang X; Lei L; Zhang Y; Kong X; Lao W; Li Z; Liu Y; Li Y; Bi C; Wu C; Zhai A
Front Microbiol; 2022; 13():1052917. PubMed ID: 36504808
[TBL] [Abstract][Full Text] [Related]
17. Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes.
Kanda N; Watanabe S
Endocrinology; 2007 May; 148(5):2317-25. PubMed ID: 17255201
[TBL] [Abstract][Full Text] [Related]
18. Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection.
Zeremski M; Dimova R; Brown Q; Jacobson IM; Markatou M; Talal AH
J Infect Dis; 2009 Dec; 200(11):1774-80. PubMed ID: 19848607
[TBL] [Abstract][Full Text] [Related]
19. The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner.
Callahan V; Hawks S; Crawford MA; Lehman CW; Morrison HA; Ivester HM; Akhrymuk I; Boghdeh N; Flor R; Finkielstein CV; Allen IC; Weger-Lucarelli J; Duggal N; Hughes MA; Kehn-Hall K
Viruses; 2021 Jun; 13(6):. PubMed ID: 34205098
[TBL] [Abstract][Full Text] [Related]
20. Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection.
Berres ML; Trautwein C; Schmeding M; Eurich D; Tacke F; Bahra M; Neuhaus P; Neumann UP; Wasmuth HE
Hepatology; 2011 Feb; 53(2):596-603. PubMed ID: 21274880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
